Davud Sirjani

Otolaryngologist, Surgical oncologist, Head and neck surgeon, Head and neck surgical oncologist

Clinical Assistant Professor, Otolaryngology (Head and Neck Surgery)
4.7 out of 5
67 Patient Ratings
9 Patient Comments

Cancer Center

  • 875 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic » Getting Here » Make An Appointment

Head and Neck Cancer Program

  • 900 Blake Wilbur Drive
  • Palo Alto, CA 94304
  • Phone: 650-498-6000
Learn More About the Clinic » Getting Here » Make An Appointment

Professional Education

Fellowship: University of Washington Medical Center (2009) WA

Board Certification: Otolaryngology, American Board of Otolaryngology (2010)

Residency: Washington University School Of Medicine (2008) MO

Internship: Washington University School Of Medicine (2002) MO

Medical Education: University of Arizona College of Medicine (2001) AZ

Honors & Awards

Faculty Teaching Award, Stanford Department of Otolaryngology (2013)

Administrative Appointments

Chief of Otolaryngology, VA Palo Alto (2012 - Present)

Patient Ratings and Comments

4.7

Friendliness

4.7

Recommended to others

4.7

Explanations

4.6

Listens

4.6

Includes you in decisions

4.7

Clear Communication

4.7

Confidence in your doctor

3.6

Wait times

SHC Patient, Dec 2014

Dr. Sirjani is awesome!

SHC Patient, Oct 2014

Very attentive and professional.

SHC Patient, Oct 2014

Though the PA's I saw were compassionate, Dr. Sirjani poked me and prodded me right where I had surgery only 10 days earlier and when I expressed pain, he acted like I shouldn't and told me I should go to 'pain management!'

SHC Patient, Oct 2014

For the first time, Dr. Sirjani seemed a bit stressed out; he was obviously running behind schedule.

View all 9 patient comments

CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma.
Murillo-Sauca, O., Chung, M. K., Shin, J. H., Karamboulas, C., Kwok, S., & Sunwoo, J. B. (2014). CD271 is a functional and targetable marker of tumor-initiating cells in head and neck squamous cell carcinoma. Oncotarget.

Neurotrophic factor GDNF promotes survival of salivary stem cells.
Xiao, N., Lin, Y., Cao, H., Sirjani, D., Giaccia, A. J., & Le, Q.-T. (2014). Neurotrophic factor GDNF promotes survival of salivary stem cells. journal of clinical investigation, 124(8), 3364-3377.

A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth.
Xiao, N., Cao, H., Chen, C.-H., Kong, C. S., Ali, R., & Le, Q.-T. (2013). A novel aldehyde dehydrogenase-3 activator (Alda-89) protects submandibular gland function from irradiation without accelerating tumor growth. Clinical cancer research , 19(16), 4455-4464.

Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy.
Sasportas, L. S., Hosford, D. N., Sodini, M. A., Waters, D. J., Zambricki, E. A., & Sirjani, D. (2013). Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy. Oral surgery, oral medicine, oral pathology and oral radiology, 116(1), e37-51.

Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy
Sasportas, L. S., Hosford, D. N., Sodini, M. A., Waters, D. J., Zambricki, E. A., & Sirjani, D. (2013). Cost-effectiveness landscape analysis of treatments addressing xerostomia in patients receiving head and neck radiation therapy. ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY, 116(1), E37-E51.

Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence
Ho, A. S., Tsao, G. J., Chen, F. W., Shen, T., Kaplan, M. J., & Yao, M. (2013). Impact of positron emission tomography/computed tomography surveillance at 12 and 24 months for detecting head and neck cancer recurrence. CANCER, 119(7), 1349-1356.

A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo
Banh, A., Xiao, N., Cao, H., Chen, C.-H., Kuo, P., & Quynh-Thu Le, Q. T. (2011). A Novel Aldehyde Dehydrogenase-3 Activator Leads to Adult Salivary Stem Cell Enrichment In Vivo. CLINICAL CANCER RESEARCH, 17(23), 7265-7272.

Lefort I Osteotomy access to the Anterior Skull Base
Sirjani DB, & Futran N. (2010). Lefort I Osteotomy access to the Anterior Skull Base. Operative Techniques in Otolaryngology, 21(1).

4.7 out of 5
67 Patient Ratings
9 Patient Comments

SHC Patient, Dec 2014

Dr. Sirjani is awesome!

SHC Patient, Oct 2014

Very attentive and professional.

SHC Patient, Oct 2014

Though the PA's I saw were compassionate, Dr. Sirjani poked me and prodded me right where I had surgery only 10 days earlier and when I expressed pain, he acted like I shouldn't and told me I should go to 'pain management!'

SHC Patient, Oct 2014

For the first time, Dr. Sirjani seemed a bit stressed out; he was obviously running behind schedule.

SHC Patient, Aug 2014

Dr. Sirjani very kind, informative and I felt like he cared about myself & my problem!!! Was prompt and efficient.

SHC Patient, Aug 2014

I saw many people - everyone excellent except for slight problem with the doctor in training who did the biopsy.

SHC Patient, Mar 2014

Good.

SHC Patient, Feb 2014

Dr. Sirjani has been wonderful in every way.

SHC Patient, Feb 2014

I have full and complete trust in Dr. Sirjani.